Top 10 echoontario.ca Competitors

projectecho.org

Check out our 2019 High School Entrepreneurs’ Business Plan Competition Winning Teams

healthproviders.sharedhealthmb.ca

Finance

sto.ca

La STO est un réseau de transport collectif qui assure la mobilité des personnes sur le territoire de la ville de Gatineau.

vcuhealth.org

Commitment to Privacy

medicine.okstate.edu

Contact OSU Center for Health Sciences

ahrq.gov

ahrq advances excellence in healthcare by producing evidence to make healthcare safer, higher quality, more accessible, equitable, and affordable.

chcs.org

This webinar will bring together state leaders from Delaware, New Jersey, and Wisconsin to discuss how they are designing and scaling contingency management programs across diverse policy and funding environments.

annfammed.org

PURPOSE Unlike in many community-based settings, benzodiazepine (BZD) prescribing to older veterans has decreased. We sought to identify health care system strategies associated with greater facility-level reductions in BZD prescribing to older adults. METHODS We completed an explanatory sequential mixed methods study of health care facilities in the Veterans Health Administration (N = 140). Among veterans aged ≥75 years receiving long-term BZD treatment, we stratified facilities into relatively high and low performance on the basis of the reduction in average daily dose of prescribed BZD from October 1, 2015 to June 30, 2017. We then interviewed key facility informants (n = 21) who led local BZD reduction efforts (champions), representing 11 high-performing and 6 low-performing facilities. RESULTS Across all facilities, the age-adjusted facility-level average daily dose in October 2015 began at 1.34 lorazepam-equivalent mg/d (SD 0.17); the average rate of decrease was −0.27 mg/d (SD 0.09) per year. All facilities interviewed, regardless of performance, used passive strategies primarily consisting of education regarding appropriate prescribing, alternatives, and identifying potential patients for discontinuation. In contrast, champions at high-performing facilities described leveraging ≥1 active strategies that included individualized recommendations, administrative barriers to prescribing, and performance measures to incentivize clinicians. CONCLUSIONS Initiatives to reduce BZD prescribing to older adults that are primarily limited to passive strategies, such as education and patient identification, might have limited success. Clinicians might benefit from additional recommendations, support, and incentives to modify prescribing practices.